Yoshio Masuda
Papers
1
Total Citations
3
H-Index
1
About
Dr. Yoshio Masuda is a clinical researcher specializing in urological oncology, with a particular focus on the complications and long-term effects of intravesical Bacillus Calmette-Guérin (BCG) immunotherapy for non-muscle-invasive bladder cancer. His most cited work, a 2023 case report and literature review, documents a rare instance of an asymptomatic renal granuloma diagnosed three years after BCG injection—a critical contribution to understanding delayed, atypical adverse events in bladder cancer treatment. This paper, with three citations, highlights his meticulous approach to post-treatment surveillance and the importance of recognizing granulomatous complications that may mimic malignancy. Dr. Masuda’s research bridges the gap between effective immunotherapy and its underreported renal sequelae, offering valuable insights for urologists managing long-term patient outcomes. His work underscores the need for vigilance in follow-up protocols, and his case report serves as a key reference for clinicians encountering similar diagnostic challenges. Through this focused investigation, Dr. Masuda has advanced the safety profile of BCG therapy, making him a notable voice in the field of urological oncology.
Research Focus
Key Achievements
Top Papers
- 1